These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 5173522)

  • 1. [The effect of divicine on human erythrocytes (author's transl)].
    Flohé L; Niebch G; Reiber H
    Z Klin Chem Klin Biochem; 1971 Sep; 9(5):431-7. PubMed ID: 5173522
    [No Abstract]   [Full Text] [Related]  

  • 2. [Favism - a familial enzymatic defect of the red blood cells in a 7-year-old girl].
    Pohorecka J; Jabłońska-Skwiecińska E; Powiertowska-Ryszka G
    Pediatr Pol; 1982; 57(9):731-4. PubMed ID: 7170153
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of divicine and isouramil on red cell metabolism in normal and G6PD-deficient (Mediterranean variant) subjects. Possible role in the genesis of favism.
    Arese P; Bosia A; Naitana A; Gaetani S; D'Aquino M; Gaetani GF
    Prog Clin Biol Res; 1981; 55():725-46. PubMed ID: 7291203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does 3,4-dihydroxyphenylalanine play a part in favism?
    Kosower NS; Kosower EM
    Nature; 1967 Jul; 215(5098):285-6. PubMed ID: 6059514
    [No Abstract]   [Full Text] [Related]  

  • 5. [Glucose-6-phosphate dehydrogenase deficiency hereditary hemolytic anemia (author's transl)].
    Labar B; Stanulović M; Jerence D
    Lijec Vjesn; 1979 Sep; 101(9):560-2. PubMed ID: 542090
    [No Abstract]   [Full Text] [Related]  

  • 6. The oxidant effect of isouramil on red cell glutathione and its synergistic enhancement by ascorbic acid or 3,4-dihydroxyphenylalanine. Possible relation to the pathogenesis of favism.
    Razin A; Hershko A; Glaser G; Mager J
    Isr J Med Sci; 1968; 4(4):852-7. PubMed ID: 5707783
    [No Abstract]   [Full Text] [Related]  

  • 7. Favism: divicine hemotoxicity in the rat.
    McMillan DC; Jollow DJ
    Toxicol Sci; 1999 Oct; 51(2):310-6. PubMed ID: 10543033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Favism in GdMediterranean heterozygous females.
    Sanna G; De Virgiliis S; Palmas C; Argiolu F; Frau F; Cao A
    Pediatr Res; 1979 Jul; 13(7):812-6. PubMed ID: 481952
    [No Abstract]   [Full Text] [Related]  

  • 9. [Determination of the content of reduced glutathione, of 6-phosphogluconate dehydrogenase, of isocitrate dehydrogenase and of adenosine triphosphate in granulocytes of normal and glucose-6-phosphate dehydrogenase deficient subjects].
    Idéo G; Bragotti R; Del Ninno E; Podda M; Dioguardi N
    Boll Soc Ital Biol Sper; 1967 Oct; 43(19):1253-7. PubMed ID: 5589835
    [No Abstract]   [Full Text] [Related]  

  • 10. [Scanning electron microscopic study of the morphological changes induced by acetylsalicylic acid in therapeutic doses in the red blood cells of a patient with a very severe G6PD deficiency and clinical manifestations of favism].
    Pazzi A; Accardo G; Aleotti A; Saletti G
    G Clin Med; 1980 Jun; 61(6):435-43. PubMed ID: 7450362
    [No Abstract]   [Full Text] [Related]  

  • 11. Favism in a Portuguese family due to a deficient glucose-phosphate dehydrogenase variant (Canton) or (cpanton-like) type.
    Kahn A; Marie J; Desbois JC; Boivin P
    Acta Haematol; 1976; 56(1):58-64. PubMed ID: 822676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of vitamin C on the relationship between leucocyte and plasma ascorbic acid concentrations and the blood glutathione concentration.
    Loh HS
    Int J Vitam Nutr Res; 1973; 43(3):363-9. PubMed ID: 4147960
    [No Abstract]   [Full Text] [Related]  

  • 13. The in vitro action of dapsone and its derivatives on normal and G6PD-deficient red cells.
    Scott GL; Rasbridge MR
    Br J Haematol; 1973 Mar; 24(3):307-17. PubMed ID: 4713632
    [No Abstract]   [Full Text] [Related]  

  • 14. Membrane lipid components of normal and glucose-6-phosphate dehydrogenase-deficient erythrocytes of asymptomatic and favic subjects.
    De Flora A; Morelli A; Benatti U; Pontremoli S; Melloni E; Salamino F; Sparatore B; Michetti M; Meloni T
    Acta Biol Med Ger; 1981; 40(4-5):563-70. PubMed ID: 7315104
    [No Abstract]   [Full Text] [Related]  

  • 15. [Glucose-6-phosphate dehydrogenase activity in the erythrocytes of children with favism, during and at various intervals after the hemolytic attack].
    Tunioli AM
    Boll Soc Ital Biol Sper; 1964 Dec; 40(24):1734-7. PubMed ID: 5877918
    [No Abstract]   [Full Text] [Related]  

  • 16. The effect of methyl oleate hydroperoxide, a possible toxic ozone intermediate, on human normal and glucose-6-phosphate dehydrogenase-deficient erythrocytes.
    Williams P; Calabrese EJ; Moore GS
    Ecotoxicol Environ Saf; 1983 Apr; 7(2):242-8. PubMed ID: 6851934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormal glucose tolerance in favism.
    Billis AG; Xefteris ED; Ioannides PJ; Papastamatis SC
    Diabetologia; 1970 Aug; 6(4):425-9. PubMed ID: 5452391
    [No Abstract]   [Full Text] [Related]  

  • 18. [Erythrocyte antioxidant enzymatic systems and serum beta-glucuronidase in subjects with favism. Preliminary results].
    Frigerio R; Sole G; Olla N; Lovicu M; Pigheddu D; Sessini AP; Passiu G; Carcassi U
    Ann Ital Med Int; 1988; 3(2):87-92. PubMed ID: 3152848
    [No Abstract]   [Full Text] [Related]  

  • 19. Pathophysiology of hemolysis in glucose-6-phosphate dehydrogenase deficiency.
    Arese P; De Flora A
    Semin Hematol; 1990 Jan; 27(1):1-40. PubMed ID: 2405494
    [No Abstract]   [Full Text] [Related]  

  • 20. [A new erythrocyte glucose-6-phosphate dehydrogenase-variant, type Frankfurt. I. Characterization of the variant by kinetical parameters (author's transl)].
    Nowicki L; Strobel S; Martin H; Koschwitz U
    Klin Wochenschr; 1974 Mar; 52(10):478-84. PubMed ID: 4408431
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.